# Nephros (NEPH) — Earnings

NEPH · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/neph/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.11 |
| EPS estimate | $0.00 |
| EPS surprise | +3233.33% |
| Revenue surprise | +20.49% |
| Revenue | $6.0M |
| Revenue estimate | $5.0M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1196298/000149315226036851/form10-q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/74891ccc-07f9-30a7-0944-8513aef282e0.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | $0.00 | $0.11 | 3233.33% | $5.0M | $6.0M |
| Q1 2026 | May 7, 2026 | $0.01 | $0.01 | 0.00% | $5.0M | $5.2M |
| Q4 2025 | Mar 12, 2026 | $0.01 | $0.01 | 0.00% | $4.5M | $4.7M |
| Q3 2025 | Nov 6, 2025 | −$0.02 | $0.03 | 250.00% | $3.9M | $4.8M |
| Q2 2025 | Aug 7, 2025 | −$0.03 | $0.02 | 180.00% | $3.7M | $4.4M |
| Q1 2025 | May 8, 2025 | −$0.01 | $0.05 | 1100.00% | $3.7M | $4.9M |
| Q4 2024 | Mar 6, 2025 | $0.03 | $0.03 | 0.00% | $3.9M | $3.9M |
| Q3 2024 | Nov 13, 2024 | −$0.02 | $0.02 | 200.00% | $3.5M | $3.5M |
| Q2 2024 | Aug 8, 2024 | −$0.02 | −$0.03 | -100.00% | $3.9M | $3.3M |
| Q1 2024 | May 9, 2024 | −$0.04 | −$0.02 | 50.00% | $3.7M | $3.5M |
| Q4 2023 | Mar 7, 2024 | −$0.03 | −$0.06 | -140.00% | $3.8M | $3.3M |
| Q3 2023 | Nov 8, 2023 | −$0.07 | −$0.02 | 69.23% | $3.4M | $3.7M |
| Q2 2023 | Aug 9, 2023 | −$0.06 | −$0.04 | 27.27% | $3.1M | $3.5M |
| Q1 2023 | May 10, 2023 | −$0.02 | −$0.03 | -50.00% | $3.7M | $3.7M |
| Q4 2022 | Mar 8, 2023 | −$0.07 | −$0.07 | -7.69% | $2.8M | $2.6M |
| Q3 2022 | Nov 2, 2022 | −$0.11 | −$0.31 | -181.82% | $2.6M | $2.4M |
| Q2 2022 | Aug 10, 2022 | −$0.14 | −$0.12 | 15.55% | $2.7M | $2.9M |
| Q1 2022 | May 4, 2022 | −$0.11 | −$0.20 | -87.44% | $3.1M | $2.2M |
| Q4 2021 | Feb 23, 2022 | −$0.11 | −$0.11 | 2.91% | $2.8M | $2.8M |
| Q3 2021 | Nov 4, 2021 | −$0.11 | −$0.12 | -12.46% | $2.7M | $2.6M |

## Frequently Asked Questions

### When did Nephros (NEPH) last report earnings?

Nephros last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did NEPH beat earnings estimates?

Yes. Nephros reported EPS of $0.11 for Q2 2026 against a $0.00 estimate — a 3233.33% beat.

### How much revenue did NEPH report last quarter?

Nephros reported $6.0M in revenue for Q2 2026, against a consensus estimate of $5.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).